Replay available

HCA Healthcare, Inc. (HCA) Q2 2025 Earnings Call

HCA Healthcare, Inc. (NYSE: HCA) Q2 2025 earnings conference call, held 2025-07-25. Replay captured from the company's public earnings webcast.

Fri, July 25, 2025 at 10:00 AMendedReplay
HCA Healthcare, Inc. (HCA) Q2 2025 Earnings Call

Hosted by

Featured presenters

Frank Morgan

Head of Investor Relations

Sam Hazen

President and Chief Executive Officer

Mike Williams

Executive Vice President and Chief Financial Officer

AJ Rice

Analyst, UBS

Anne Hines

Analyst, Mizuho

Ben Hendricks

Analyst, RBC Capital Markets

Brian Tankulat

Analyst, Jefferies

Peter Chickering

Analyst, Deutsche Bank

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Hca Healthcare, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.195 Other factors may cause actual results to differ materially from those that might be 00:00:04.195 -- 00:00:08.158 expressed today. More information on forward-looking statements and these factors are 00:00:08.158 -- 00:00:12.602 listed in today's press release and in our various SEC filings. 00:00:12.602 -- 00:00:16.786 On this morning's call, we may reference measures such as adjusted EBITDA, which is a 00:00:16.786 -- 00:00:22.311 non-GAAP financial measure. A table providing supplemental information on adjusted EBITDA 00:00:22.311 -- 00:00:25.855 and reconciling net income attributable to HCA Healthcare, Inc. 00:00:25.855 -- 00:00:30.617 is included in today's release. This morning's call is being recorded, and a replay of 00:00:30.617 -- 00:00:35.022 the call will be available later today. With that, I'll now turn the call over to Sam. 00:00:35.022 -- 00:00:38.406 All right. Thank you, Frank, and good morning to everybody, and thank you for joining 00:00:38.406 -- 00:00:43.493 the call. The company's financial results for the second quarter were strong, with 00:00:43.493 -- 00:00:48.719 a 24% increase in diluted earnings per share, as adjusted 00:00:48.719 -- 00:00:52.001 to $6.84. The results 00:00:52.444 -- 00:00:56.714 reflected solid revenue growth of 6.4%, 00:00:56.714 -- 00:01:01.882 which was driven by greater demand for our services, improved payer mix, 00:01:01.882 -- 00:01:06.991 and consistent patient acuity levels. In the quarter, we also experienced 00:01:06.991 -- 00:01:13.201 a stable operating environment, which allowed us to produce better margins. 00:01:13.201 -- 00:01:18.590 Because of the team's great start to the year, we increased our guidance for 2025 as 00:01:18.590 -- 00:01:21.908 reflected in our earni...